[go: up one dir, main page]

AR029307A1 - Composicion para la estimulacion de la sintesis del pigmento melanico y procedimiento para su obtencion - Google Patents

Composicion para la estimulacion de la sintesis del pigmento melanico y procedimiento para su obtencion

Info

Publication number
AR029307A1
AR029307A1 ARP990103684A ARP990103684A AR029307A1 AR 029307 A1 AR029307 A1 AR 029307A1 AR P990103684 A ARP990103684 A AR P990103684A AR P990103684 A ARP990103684 A AR P990103684A AR 029307 A1 AR029307 A1 AR 029307A1
Authority
AR
Argentina
Prior art keywords
synthesis
composition
procedure
obtaining
estimulation
Prior art date
Application number
ARP990103684A
Other languages
English (en)
Original Assignee
Ct De Histoterapia Placentaria
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ct De Histoterapia Placentaria filed Critical Ct De Histoterapia Placentaria
Publication of AR029307A1 publication Critical patent/AR029307A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48Reproductive organs
    • A61K35/50Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/98Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
    • A61K8/981Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of mammals or bird
    • A61K8/982Reproductive organs; Embryos, Eggs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/04Preparations for care of the skin for chemically tanning the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Dermatology (AREA)
  • Cell Biology (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pregnancy & Childbirth (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Birds (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Composicion para la estimulacion de la síntesis del pigmento melánico constituida por una mezcla de extracto alcoholicol de placenta humana al 50% conteniendo cloruro de calcio a una concentracion entre 0,2 y 4, 0 mg/ml. El procedimiento para su obtencion comprenden la trituracion y maceracion de cotiledones placentarios congelados en etanol, seguido de filtrado. El sobrenadante se procesa con diferentes solventes orgánicos, redisolviéndose el ultimo precipitado en una solucion de cloruro de calcio en etanol. La composicion tiene aplicaccion en la estimulacion de la síntesis de pigmento melánico de la piel y en el tratamiento del vitiligo.
ARP990103684A 1998-07-28 1999-07-27 Composicion para la estimulacion de la sintesis del pigmento melanico y procedimiento para su obtencion AR029307A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CU1998110A CU22695A1 (es) 1998-07-28 1998-07-28 Formulación para la estimulación de la síntesis del pigmento melánico

Publications (1)

Publication Number Publication Date
AR029307A1 true AR029307A1 (es) 2003-06-25

Family

ID=5459380

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP990103684A AR029307A1 (es) 1998-07-28 1999-07-27 Composicion para la estimulacion de la sintesis del pigmento melanico y procedimiento para su obtencion

Country Status (16)

Country Link
US (1) US6660305B1 (es)
EP (1) EP1101494B1 (es)
JP (1) JP2002521453A (es)
CN (1) CN1187059C (es)
AR (1) AR029307A1 (es)
AT (1) ATE284699T1 (es)
BG (1) BG105208A (es)
BR (1) BR9913345A (es)
CA (1) CA2336526A1 (es)
CU (1) CU22695A1 (es)
DE (1) DE69922662D1 (es)
HU (1) HUP0103274A2 (es)
MX (1) MXPA01001014A (es)
RU (1) RU2225716C2 (es)
UA (1) UA63015C2 (es)
WO (1) WO2000006180A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100421660C (zh) * 2003-08-05 2008-10-01 胎盘组织治疗中心 治疗白癜风的组合物
CN101605566A (zh) * 2006-10-13 2009-12-16 利莱恩斯生命科学有限公司 生物聚合物上的培养黑素细胞
EA013133B1 (ru) * 2008-12-26 2010-02-26 Некоммерческое Учреждение "Научно-Исследовательский Институт Цитохимии И Молекулярной Фармакологии" Композиция аминокислот подъязычного применения для повышения репигментации кожного покрова при витилиго и способ ее применения
RU2405560C1 (ru) * 2009-05-29 2010-12-10 Общество С Ограниченной Ответственностью "Медицинский Исследовательский Центр "Иммункулус" Средство для защиты клеток мозга
CN102266586B (zh) * 2011-06-28 2013-12-04 江苏省人民医院 白癜风黑素细胞移植涂布载体系统的制备方法
FR3051204B1 (fr) 2016-05-10 2018-05-04 Rkm Engin roulant, notamment pour la depose au sol, sous forme d’un lit, de materiaux en vrac

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE454745B (sv) * 1982-12-10 1988-05-30 Cubana Importadora Y Exportado Produkt for att stimulera syntesen av melanotiskt pigment i huden vid botande av vigiligo
US4507277A (en) * 1983-04-08 1985-03-26 Empresa Cubana Importadora Y Exportadora De Productos Medicos Composition and method for stimulating the synthesis of the melanotic pigment of the skin
RU2040263C1 (ru) * 1992-01-17 1995-07-25 Научно-исследовательский институт текстильных материалов Способ получения меланина
RU2083214C1 (ru) * 1993-04-23 1997-07-10 Голоунин Александр Васильевич Способ получения меланина
CA2250000C (en) * 1996-03-28 2010-06-15 Trustees Of Boston University Methods of modulating melanin synthesis
US5690966A (en) * 1996-10-17 1997-11-25 Council Of Scientific & Industrial Research Process for the preparation of an extract from human placenta containing glycosphingolipids and endothelin-like constituent peptides useful for the treatment of vitiligo
US6451358B2 (en) * 1999-12-29 2002-09-17 Mileuna, Inc. Composition and method for the treatment of vitiligo

Also Published As

Publication number Publication date
UA63015C2 (en) 2004-01-15
EP1101494B1 (en) 2004-12-15
WO2000006180A1 (es) 2000-02-10
DE69922662D1 (de) 2005-01-20
MXPA01001014A (es) 2002-06-04
ATE284699T1 (de) 2005-01-15
CU22695A1 (es) 2001-07-31
HK1037520A1 (en) 2002-02-15
CA2336526A1 (en) 2000-02-10
US6660305B1 (en) 2003-12-09
CN1187059C (zh) 2005-02-02
EP1101494A1 (en) 2001-05-23
JP2002521453A (ja) 2002-07-16
RU2225716C2 (ru) 2004-03-20
BG105208A (en) 2001-07-31
CN1316905A (zh) 2001-10-10
BR9913345A (pt) 2001-10-16
HUP0103274A2 (hu) 2002-01-28

Similar Documents

Publication Publication Date Title
CY1119951T1 (el) Συνθεσεις για αυξηση δραστηριοτητας τελομερασης και αγωγη λοιμωξης hiv
BR0008365A (pt) 2-amino-6-anilino-purinas e o seu uso comomedicamento
ZA200004260B (en) Treatment of skin disorders.
ATE239498T1 (de) Entzündungshemmende zusammensetzung
DE59905484D1 (de) Pyrrolizidinalkaloidfreie petasites enthaltende zusammensetzung
BR0013966A (pt) Compostos espiroeterocìclicos úteis como inibidores reversìveis de proteases de cisteìna
ATE415962T1 (de) Verwendung von asiatsäure oder asiaticosid zur behandlung von krebs
SE9603533D0 (sv) Specific peptides for the treatment of deabetes mellitus
BR9808509A (pt) Composições e métodos para o tratamento e diagnóstico do câncer de mama
AR029307A1 (es) Composicion para la estimulacion de la sintesis del pigmento melanico y procedimiento para su obtencion
DE602004016376D1 (de) Kombination von et-743 mit 5-fluorouracil pro-drugs zur behandlung von krebs
ATE427746T1 (de) 5-methylindirubin zur verwendung in der behandlung von menschlichen festen tumoren
AR016254A1 (es) Una composicion de celulas de tumor modificadas con un hapteno o extracto de celulas tumorales y uso de la misma en la elaboracion de un medicamento.
CA2212563A1 (en) Process for obtaining medically active fractions from sea cucumbers
MXPA00010254A (es) Tratamiento de disfuncion sexual en ciertos grupos de pacientes.
NO970178D0 (no) Terpenoidderivater (sarcodictyiner) som er nyttige som antitumormidler
YU60199A (sh) Nove soli bpc peptida sa organo-zaštitnom aktivnošću, postupak za njihovo dobijanje i njihova primena u terapiji
DK0650473T3 (da) Radioafbildende og radiokemoterapeutiske ethanoliske thiotheraminer og acylderivater deraf ved diagnosticering og behandling af pigmenteringssygdomme
Radhakrishnan et al. Effect of licorice (Glycyhrriza glabra Linn.), a skin-whitening agent on Black molly (Poecilia latipinnaa)
DE60008077D1 (de) Matrixprotein zusammensetzungen um apoptose zu induzieren
Kuczkowski Beneficial properties of snail slime, its use in medicine and cosmetology–a review of current research
BR9607178A (pt) Antagonista de peptìdeo de hormÈnio estimulando alfa -melanócitos, processos para a inibição da atividade de hormÈnio estimulando alfa-melanócitos em um tecido ou célula que responde a hormÈnio estimulando alfa -melanócitos, para o clareamento da complexação de um animal e para o tratamento de melanoma maligno, composição farmacêutica, e, kit
AR077577A2 (es) Polipeptidos relacionados con cancer de colon humano, polinucleotidos que lo codifican, vector, usos y composiciones farmaceuticas
DE60143132D1 (de) Zusammensetzungen aus organischen extrakten von geum japonicum thunb var. und ihre verwendung
WO1997040073A3 (de) BIOLOGISCH AKTIVER EIWEISSSTOFF - KOLLAGENFRAGMENT HF-COLL-18/514cf - ZUR HEMMUNG DES WACHSTUMS VON TUMOREN UND VON GEFÄSSWUCHERUNGEN

Legal Events

Date Code Title Description
FB Suspension of granting procedure